US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)

17.50

0.0000

Volume:- -

Turnover:8.26K

Market Cap:1.97B

PE:-8.67

High:17.50

Open:17.50

Low:17.50

Close:17.50

52wk High:29.99

52wk Low:7.16

Shares:112.63M

Float Shares:112.63M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.0190

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

BRIEF-NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

BRIEF-Newamsterdam Pharma Highlights 2025 Achievements And Outlines 2026 Strategic Priorities

NewAmsterdam Pharma Company Nv - Ema Approval Decision for Obicetrapib Expected in H2 2026

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NAMSW"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMSW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV C/WTS 22/11/2027 (TO PUR COM)","latestPrice":17.5,"timestamp":1777569528218,"preClose":17.5,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":112628458,"shares":112628458,"eps":-2.019,"marketStatus":"Trading","change":0,"latestTime":"04-30 13:18:48 EDT","open":17.5,"high":17.5,"low":17.5,"amount":8259.499897,"amplitude":0,"askPrice":22.23,"askSize":100,"bidPrice":15.92,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.019,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777579200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":17.5,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMSW\",,,,,undefined,":{"symbol":"NAMSW","floatShares":112628458,"roa":"--","roe":"--","lyrEps":0,"shares":112628458,"dividePrice":0,"high":17.5,"amplitude":0,"preClose":17.5,"low":17.5,"week52Low":7.155,"pbRate":"--","week52High":29.99,"institutionHeld":0,"latestPrice":17.5,"eps":-2.019,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.019,"open":17.5,"prevYearClose":23,"prevWeekClose":19.2,"prevMonthClose":20.04,"prevQuarterClose":20.04,"fiveDayClose":22.21,"twentyDayClose":20.04,"sixtyDayClose":20},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMSW\",params:#limit:5,,,undefined,":[{"date":"2026-02-18","symbol":"NAMSW","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771405200000,"name":null,"time":"Pre-Market","dateTimestamp":1771390800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMSW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMSW\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMSW\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624809156","title":"NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624809156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624809156?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:43","pubTimestamp":1775166222,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nTUA54DL0J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAMSW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617465827","title":"BRIEF-NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2617465827","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617465827?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:44","pubTimestamp":1772833445,"startTime":"0","endTime":"0","summary":"BRIEF-NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)March 6 (Reuters) - NewAmsterdam Pharma Company NV KH6.F:NEWAMSTERDAM PHARMA REPORTS INDUCEMENT GRANTS UNDER NAS","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nTUA2ZHQLM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMSW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602379355","title":"BRIEF-Newamsterdam Pharma Highlights 2025 Achievements And Outlines 2026 Strategic Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2602379355","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602379355?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:36","pubTimestamp":1767965765,"startTime":"0","endTime":"0","summary":"BRIEF-Newamsterdam Pharma Highlights 2025 Achievements And Outlines 2026 Strategic PrioritiesJan 9 (Reuters) - NewAmsterdam Pharma Company NV KH6.F:NEWAMSTERDAM PHARMA HIGHLIGHTS 2025 ACHIEVEMENTS AND","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nTUA62DKLJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMSW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602890376","title":"NewAmsterdam Pharma Company Nv - Ema Approval Decision for Obicetrapib Expected in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602890376","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602890376?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:00","pubTimestamp":1767963602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nTUA62DKLJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAMSW"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NAMSW\",params:#limit:6,delay:false,,,undefined,":[]}}